• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们是否应该考虑结核病的“第四个 90%”?

Should we consider a 'fourth 90' for tuberculosis?

机构信息

International Union Against Tuberculosis and Lung Disease, Paris, France, Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London.

International Union Against Tuberculosis and Lung Disease, Paris, France.

出版信息

Int J Tuberc Lung Dis. 2019 Dec 1;23(12):1253-1256. doi: 10.5588/ijtld.19.0471. Epub 2019 Nov 21.

DOI:10.5588/ijtld.19.0471
PMID:31753065
Abstract

The international community has committed to end the tuberculosis (TB) epidemic by 2030. To facilitate the meeting of the global incidence and mortality indicators set by the World Health Organization's End TB Strategy, the Stop TB Partnership launched the three 90-(90)-90 diagnostic and treatment targets in 2014. In this paper, we argue that a 'fourth 90'-Ensuring that 90% of all people successfully completing treatment for TB can have a good health-related quality of life'-should be considered. Many individuals who successfully complete anti-TB treatment are burdened with lifelong comorbidities-human immunodeficiency virus (HIV) and diabetes mellitus, obstructive and restrictive lung disease, involving lung destruction, cavitation, fibrosis and bronchiectasis, that either pre-existed or developed as a result of TB (e.g., chronic pulmonary aspergillosis), permanent disabilities such as hearing loss resulting from second-line anti-TB drugs, and mental health disorders. These need to be identified during TB treatment and appropriate care and support provided after anti-TB treatment is successfully completed. A 'fourth 90' has also been proposed for the UNAIDS 90-90-90 targets similar in scope to what is being suggested here for TB. Adoption by both HIV and TB control programmes would highlight the current focus on integrated person- and family-centred services.

摘要

国际社会承诺到 2030 年终结结核病(TB)流行。为了促进实现世界卫生组织《终止结核病战略》所设定的全球发病率和死亡率指标,遏制结核病伙伴关系于 2014 年推出了三个 90-(90)-90 诊断和治疗目标。在本文中,我们提出应考虑第四个 90-确保 90%成功完成结核病治疗的人能够拥有良好的健康相关生活质量。许多成功完成抗结核治疗的人都承受着终身合并症的负担——人类免疫缺陷病毒(HIV)和糖尿病、阻塞性和限制性肺病,涉及肺部破坏、空洞形成、纤维化和支气管扩张,这些疾病要么是在结核病之前存在,要么是由结核病引起的(例如慢性肺曲霉病),永久性残疾如二线抗结核药物导致的听力损失,以及心理健康障碍。这些需要在结核病治疗期间识别,并在成功完成抗结核治疗后提供适当的护理和支持。UNAIDS 的 90-90-90 目标也提出了第四个 90,其范围与这里为结核病建议的范围相似。艾滋病毒和结核病控制规划的采用将突出目前对以人为中心和家庭为中心的综合服务的关注。

相似文献

1
Should we consider a 'fourth 90' for tuberculosis?我们是否应该考虑结核病的“第四个 90%”?
Int J Tuberc Lung Dis. 2019 Dec 1;23(12):1253-1256. doi: 10.5588/ijtld.19.0471. Epub 2019 Nov 21.
2
Tuberculosis结核病
3
API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.《2006年抗结核药物国际共识指南:肺结核、肺外结核及特殊情况结核病的管理》
J Assoc Physicians India. 2006 Mar;54:219-34.
4
[Fight against tuberculosis in the world].[全球抗击结核病]
Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):181-7. doi: 10.1016/j.pneumo.2014.03.004. Epub 2014 May 28.
5
How human immunodeficiency virus voluntary testing can contribute to tuberculosis control.人类免疫缺陷病毒自愿检测如何有助于结核病控制。
Bull World Health Organ. 2002;80(12):939-45. Epub 2003 Jan 23.
6
[Tuberculosis in Asia].[亚洲的结核病]
Kekkaku. 2002 Oct;77(10):693-7.
7
Tuberculosis and human immunodeficiency virus infection in developing countries.发展中国家的结核病与人类免疫缺陷病毒感染
Lancet. 1990 Feb 17;335(8686):387-90. doi: 10.1016/0140-6736(90)90216-r.
8
Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable?从结核病控制到消除:我们在哪里?有哪些变量和限制?这是否可行?
Int J Infect Dis. 2017 Mar;56:30-33. doi: 10.1016/j.ijid.2016.11.416. Epub 2016 Dec 1.
9
Tuberculosis: a new vision for the 21st century.结核病:21世纪的新视角。
Kekkaku. 2009 Nov;84(11):721-6.
10
Turning the tide against tuberculosis.扭转结核病蔓延态势。
Int J Infect Dis. 2017 Mar;56:6-9. doi: 10.1016/j.ijid.2017.01.012. Epub 2017 Feb 4.

引用本文的文献

1
Prevalence of TB-related symptoms and self-reported disability among adult TB survivors.成年结核病幸存者中与结核病相关症状及自我报告残疾的患病率。
IJTLD Open. 2024 Dec 1;1(12):540-546. doi: 10.5588/ijtldopen.24.0141. eCollection 2024 Dec.
2
Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe.肯尼亚、乌干达、赞比亚和津巴布韦结核病治疗结束时的残疾、合并症及风险决定因素。
IJTLD Open. 2024 May 1;1(5):197-205. doi: 10.5588/ijtldopen.24.0082. eCollection 2024 May.
3
Beyond the diagnosis of drug-resistant Tuberculosis in Norway: patients' experiences before, during and after treatment.
挪威耐药结核病诊断之外:患者治疗前后的经历。
BMC Public Health. 2024 Jul 6;24(1):1801. doi: 10.1186/s12889-024-19342-8.
4
Risk factors for pulmonary tuberculosis recurrence, relapse and reinfection: a systematic review and meta-analysis.肺结核复发、再发和再感染的危险因素:系统评价和荟萃分析。
BMJ Open Respir Res. 2024 Mar 13;11(1):e002281. doi: 10.1136/bmjresp-2023-002281.
5
Post-TB health and wellbeing.肺结核治愈后的健康与福祉。
Int J Tuberc Lung Dis. 2023 Apr 1;27(4):248-283. doi: 10.5588/ijtld.22.0514.
6
Stakeholder perspectives around post-TB wellbeing and care in Kenya and Malawi.肯尼亚和马拉维利益相关者对结核病康复及后续护理的看法。
PLOS Glob Public Health. 2022 Sep 7;2(9):e0000510. doi: 10.1371/journal.pgph.0000510. eCollection 2022.
7
Revamping of Chronic Respiratory Diseases in Low- and Middle-Income Countries.中低收入国家慢性呼吸系统疾病改革。
Front Public Health. 2022 Feb 21;9:757089. doi: 10.3389/fpubh.2021.757089. eCollection 2021.
8
HIV-Associated Tuberculosis in Children and Adolescents: Evolving Epidemiology, Screening, Prevention and Management Strategies.儿童和青少年中的HIV相关结核病:不断演变的流行病学、筛查、预防及管理策略
Pathogens. 2021 Dec 29;11(1):33. doi: 10.3390/pathogens11010033.
9
The efficacy of Jujube syrup on the prevention of drug-induced hepatotoxicity in pulmonary tuberculosis patients: A pilot randomized double-blind placebo-controlled clinical trial.大枣糖浆预防肺结核患者药物性肝损伤的疗效:一项前瞻性随机双盲安慰剂对照临床试验。
Pharmacol Res Perspect. 2022 Feb;10(1):e00902. doi: 10.1002/prp2.902.
10
Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae.由于发病的结核病导致的终生疾病负担:包括结核后后遗症在内的全球再评估。
Lancet Glob Health. 2021 Dec;9(12):e1679-e1687. doi: 10.1016/S2214-109X(21)00367-3.